用户,您好,欢迎您进入NSTL重点领域信息门户! 登录 | 注册  帮助中心
重点领域信息门户
您当前的位置: 首页 > [2018年第2期]情报条目详细信息

编译内容

编译服务: 心血管疾病防治 编译者: 张燕舞 编译时间: May 22, 2018 浏 览 量: 1

地高辛在心房颤动(AF)房率控制中的作用多年来基于对死亡率增加的担忧而受到质疑。 ARISTOTLE试验(比较大约18,000例房颤患者的抗凝治疗)的一项表现良好的事后亚组分析显示,地高辛的使用与≥1.2ng / mL水平的死亡风险显着相关。 我们几乎从不使用地高辛作为第一个控制率的药物,很少将其添加到其他控制率的药物中。

BACKGROUND Digoxin is widely used in patients with atrial fibrillation (AF).

OBJECTIVES The goal of this paper was to explore whether digoxin use was independently associated with increased mortality in patients with AF and if the association was modified by heart failure and/or serum digoxin concentration.

METHODS The association between digoxin use and mortality was assessed in 17,897 patients by using a propensity score-adjusted analysis and in new digoxin users during the trial versus propensity score-matched control participants. The authors investigated the independent association between serum digoxin concentration and mortality after multivariable adjustment.

RESULTS At baseline, 5,824 (32.5%) patients were receiving digoxin. Baseline digoxin use was not associated with an increased risk of death (adjusted hazard ratio [HR]: 1.09; 95% confidence interval [CI]: 0.96 to 1.23; p = 0.19). However, patients with a serum digoxin concentration ≥1.2 ng/ml had a 56% increased hazard of mortality (adjusted HR: 1.56; 95% CI: 1.20 to 2.04) compared with those not on digoxin. When analyzed as a continuous variable, serum digoxin concentration was associated with a 19% higher adjusted hazard of death for each 0.5-ng/ml increase (p = 0.0010); these results were similar for patients with and without heart failure. Compared with propensity score-matched control participants, the risk of death (adjusted HR: 1.78; 95% CI: 1.37 to 2.31) and sudden death (adjusted HR: 2.14; 95% CI: 1.11 to 4.12) was significantly higher in new digoxin users.

CONCLUSIONS In patients with AF taking digoxin, the risk of death was independently related to serum digoxin concentration and was highest in patients with concentrations ≥1.2 ng/ml. Initiating digoxin was independently associated with higher mortality in patients with AF, regardless of heart failure.

  
提供服务
导出本资源